Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity
TORONTO, Oct. 22, 2025 /PRNewswire/ — Visionary Holdings Inc. ("GV" or the…